由施普林格出版。ISSN: 1535 - 1084。馬克·馬特森(Mark Mattson)是《分子神經(jīng)科學(xué)雜志》(Journal of Molecular Neuroscience, JMN)的聯(lián)合編輯，現(xiàn)在與克里斯汀·范布羅克霍文(Christine van Broeckhoven)和約翰·哈代(John Hardy)合作，為神經(jīng)疾病的分子遺傳學(xué)、生物化學(xué)和細(xì)胞生物學(xué)開發(fā)了一個更專注的場所。神經(jīng)分子醫(yī)學(xué)(JMN的B部分)致力于在這些令人興奮的研究領(lǐng)域發(fā)表高質(zhì)量的原創(chuàng)研究和批判性評論。神經(jīng)分子醫(yī)學(xué)將包括分子遺傳學(xué)、信號轉(zhuǎn)導(dǎo)、可塑性和細(xì)胞死亡領(lǐng)域的基礎(chǔ)研究，并將特別關(guān)注旨在將遺傳異常與神經(jīng)發(fā)病的細(xì)胞和分子機(jī)制連接起來的合成研究和綜述。發(fā)表在NMM上的信息將為神經(jīng)系統(tǒng)的分子醫(yī)學(xué)的未來提供一個窗口。

Published by Springer. ISSN: 1535-1084.Mark Mattson has been coeditor of the Journal of Molecular Neuroscience (JMN) and is now, with Christine van Broeckhoven and John Hardy, developing a more focused venue for the molecular genetics, biochemistry and cell biology of neurological disorders. NeuroMolecular Medicine (Part B of JMN) is committed to publishing high quality original research and critical reviews in these exciting areas of research. NeuroMolecular Medicine will encompass basic research in the fields of molecular genetics, signal transduction, plasticity, and cell death, and will give special attention to synthetic research and reviews that aim to bridge genetic aberrancies with cellular and molecular mechanisms of neurological pathogenesis. The information published in NMM will provide a window into the future of molecular medicine for the nervous system.